These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21285998)

  • 1. Clinical Presentation of Inherited Metabolic Diseases in Newborns Hospitalised in an Intensive Care Unit.
    Teixeira C; Cordeiro C; Pinto C; Diogo L
    J Mother Child; 2023 Jun; 27(1):55-63. PubMed ID: 37843971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Newborn hearing screening in Germany-results of the 2011/2012 and 2017/2018 evaluations].
    Brockow I; Söhl K; Hanauer M; Heißenhuber A; Marzi C; Am Zehnhoff-Dinnesen A; Matulat P; Mansmann U; Nennstiel U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1259-1267. PubMed ID: 37843595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases].
    Mütze U; Kölker S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1249-1258. PubMed ID: 37815612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing metabolic disease: Part I.
    Cell Metabolism editorial team
    Cell Metab; 2024 Feb; 36(2):223. PubMed ID: 38325334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caring for a Child with Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening: Parental Health-Related Quality of Life, Coping Patterns, and Needs.
    Rautmann L; Witt S; Theiding C; Odenwald B; Nennstiel-Ratzel U; Dörr HG; Quitmann JH
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.
    Martín-Rivada Á; Palomino Pérez L; Ruiz-Sala P; Navarrete R; Cambra Conejero A; Quijada Fraile P; Moráis López A; Belanger-Quintana A; Martín-Hernández E; Bellusci M; Cañedo Villaroya E; Chumillas Calzada S; García Silva MT; Bergua Martínez A; Stanescu S; Martínez-Pardo Casanova M; Ruano MLF; Ugarte M; Pérez B; Pedrón-Giner C
    JIMD Rep; 2022 Mar; 63(2):146-161. PubMed ID: 35281663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global impact of COVID-19 on newborn screening programmes.
    Koracin V; Loeber JG; Mlinaric M; Battelino T; Bonham JR; Groselj U;
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35236661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Newborn Screening Program in Slovenia using Tandem Mass Spectrometry and Confirmatory Next Generation Sequencing Genetic Testing.
    Lampret BR; Remec ŽI; Torkar AD; Tanšek MŽ; Šmon A; Koračin V; Čuk V; Perko D; Ulaga B; Jelovšek AM; Debeljak M; Kovač J; Battelino T; Grošelj U
    Zdr Varst; 2020 Dec; 59(4):256-263. PubMed ID: 33133282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Screening for Metabolic Disorders in the Slovenian Pediatric Population.
    Lampret BR; Murko S; Tanšek MŽ; Podkrajšek KT; Debeljak M; Šmon A; Battelino T
    J Med Biochem; 2015 Jan; 34(1):58-63. PubMed ID: 28356825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn Screening in Slovenia.
    Šmon A; Grošelj U; Žerjav Tanšek M; Biček A; Oblak A; Zupančič M; Kržišnik C; Repič Lampr Et B; Murko S; Hojker S; Battelino T
    Zdr Varst; 2015 Jun; 54(2):86-90. PubMed ID: 27646913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants.
    Frömmel C; Brose A; Klein J; Blankenstein O; Lobitz S
    Biomed Res Int; 2014; 2014():695828. PubMed ID: 25147811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
    Lobitz S; Frömmel C; Brose A; Klein J; Blankenstein O
    Eur J Hum Genet; 2014 Aug; 22(8):1051-3. PubMed ID: 24398797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year evaluation of a neonatal screening program for cystic fibrosis in Switzerland.
    Rueegg CS; Kuehni CE; Gallati S; Baumgartner M; Torresani T; Barben J;
    Dtsch Arztebl Int; 2013 May; 110(20):356-63. PubMed ID: 23825488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for metabolic and endocrine disorders.
    Harms E; Olgemöller B
    Dtsch Arztebl Int; 2011 Jan; 108(1-2):11-21; quiz 22. PubMed ID: 21285998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correspondence (letter to the editor): Comment on the positive predictive value.
    Wolter C
    Dtsch Arztebl Int; 2011 Apr; 108(16):284; author reply 284. PubMed ID: 21603568
    [No Abstract]   [Full Text] [Related]  

  • 17. Newborn screening in Delaware.
    Bartoshesky LE
    Del Med J; 2003 May; 75(5):181-9. PubMed ID: 12815929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for metabolic, endocrine, infectious, and genetic disorders. Current and future directions.
    Larsson A
    Clin Perinatol; 2001 Jun; 28(2):449-61. PubMed ID: 11499065
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.